Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KYMR
Stock Latest News
Company Announcements
Kymera Therapeutics Speeds Pipeline Amid Rising Spend
5d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $135 from $119 at Morgan Stanley
19d ago
KYMR
Premium
Ratings
Kymera: Advancing STAT6 Pipeline, De-Risking Milestones, and Raised Price Target to $135 Support Buy Rating
19d ago
KYMR
Premium
Ratings
Analyst Reiterates Buy on Kymera, Citing Favorable BROADEN2 Design and Compelling KT-621 Risk-Reward in Atopic Dermatitis
19d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $135 from $120 at Citi
19d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $139 from $133 at Barclays
19d ago
KYMR
Premium
The Fly
Kymera Therapeutics reports Q2 EPS (62c), consensus (74c)
20d ago
KYMR
Premium
The Fly
Humana upgraded, Las Vegas Sands downgraded: Wall Street’s top analyst calls
26d ago
BE
PG
Premium
The Fly
Kymera Therapeutics initiated with a Hold at Deutsche Bank
27d ago
KYMR
Premium
Ratings
KBIO’s KT-579 IRF5 Degrader Drives Buy Rating as Analyst Lifts Price Target to $135 on Lupus Upside Potential
28d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $135 from $125 at Guggenheim
28d ago
KYMR
Premium
Company Announcements
Kymera Therapeutics Appoints New Chief Medical Officer
29d ago
8K
KYMR
Premium
The Fly
Kymera Therapeutics CMO Jared Gollob to retire, Terence Rooney to succeed
29d ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $140 from $120 at Mizuho
1M ago
KYMR
Premium
The Fly
American Express, Biogen upgraded: Wall Street’s top analyst calls
1M ago
AXP
BBY
Premium
The Fly
Kymera Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
1M ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $125 from $110 at BofA
2M ago
KYMR
Premium
Ratings
Kymera Therapeutics: Accelerated KT-621 Development, $6B Peak Sales Potential, and Raised Price Target to $125 Support Buy Rating
2M ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $155 from $117 at B. Riley
2M ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $136 from $116 at Truist
2M ago
KYMR
Premium
The Fly
Kymera Therapeutics price target raised to $129 from $106 at Canaccord
2M ago
KYMR
Premium
Ratings
Kymera: Accelerated Atopic Dermatitis Timeline and KT-621 Potential Drive Jeet Mukherjee’s Buy Rating
2M ago
KYMR
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
